About Regeneron Pharmaceuticals, Inc. (REGN)
Regeneron Pharmaceuticals, Inc. (REGN) is a publicly traded company in the Healthcare sector, specifically in the Biotechnology industry. View real-time stock data, AI analysis, options flow, and convergence signals for REGN on iGotFomo.
REGN Key Statistics
| Current Price | $649.76 | Market Cap | $68.1 billion |
|---|---|---|---|
| Daily Change | +3.09% | Volume | 1.0M |
| 52-Week High | $821.11 | 52-Week Low | $476.49 |
| P/E Ratio (TTM) | 15.36 | Forward P/E | 12.08 |
| Sector | Healthcare | Industry | Biotechnology |
Frequently Asked Questions About REGN
- What is Regeneron Pharmaceuticals, Inc. (REGN)?
- Regeneron Pharmaceuticals, Inc. (REGN) is a publicly traded company in the Healthcare sector, operating in the Biotechnology industry.
- What is the current REGN stock price?
- As of the latest trading session, REGN trades at $649.76 per share, with a daily change of +3.09%.
- What is REGN's market capitalization?
- Regeneron Pharmaceuticals, Inc. has a market capitalization of $68.1 billion, making it a large-cap stock.
- What sector does REGN belong to?
- Regeneron Pharmaceuticals, Inc. operates in the Healthcare sector, specifically in the Biotechnology industry. View all Healthcare stocks.
